These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 22985347)

  • 1. Updates from the Sixth International Congress 'Psoriasis: from Gene to Clinic', the Queen Elizabeth II Conference Centre, London, U.K., 1-3 December 2011.
    Shams K; Burden AD
    Br J Dermatol; 2012 Oct; 167(4):757-61. PubMed ID: 22985347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Updates from the Fourth International Congress 'psoriasis: from gene to clinic', the Royal College of Physicians, London, UK, 1-3 December 2005.
    Camp RD
    Br J Dermatol; 2006 Dec; 155(6):1124-30. PubMed ID: 17107378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psoriasis: from gene to clinic.
    Izco-Basurko I
    Drug News Perspect; 2009 Apr; 22(3):177-9. PubMed ID: 19440561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psoriasis: From Gene to Clinic, 9
    Br J Dermatol; 2022 Jan; 186(1):e2-e82. PubMed ID: 34988979
    [No Abstract]   [Full Text] [Related]  

  • 5. Updates from the Third International Congress on Psoriasis: From Gene to Clinic, The Royal College of Physicians, London, U.K., 21-23 November 2002.
    Camp RD
    Br J Dermatol; 2003 May; 148(5):878-84. PubMed ID: 12786816
    [No Abstract]   [Full Text] [Related]  

  • 6. Recent progress in unraveling the complexities of receptor biology: towards new therapeutics.
    Watkins HA; Hay DL
    Expert Rev Clin Pharmacol; 2012 Mar; 5(2):145-7. PubMed ID: 22390556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. American Academy of Dermatology - 2010 summer meeting.
    Carlos M; Goldenberg G
    IDrugs; 2010 Oct; 13(10):683-5. PubMed ID: 20878586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psoriasis: an evidence-based update. Report of the 9th evidenced based update meeting, 12 May 2011, Loughborough, UK.
    De Mozzi P; Johnston GA; Alexandroff AB
    Br J Dermatol; 2012 Feb; 166(2):252-60. PubMed ID: 22268857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody engineering and therapeutics conference. The annual meeting of the antibody society, Huntington Beach, CA, December 7-11, 2014.
    Larrick JW; Parren P; Huston JS; Plückthun A; Bradbury A; Tomlinson IM; Chester KA; Burton DR; Adams GP; Weiner LM; Scott JK; Alfenito MR; Veldman T; Reichert JM
    MAbs; 2014; 6(5):1115-23. PubMed ID: 25517297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-17 targeted therapies for psoriasis.
    Chiricozzi A; Krueger JG
    Expert Opin Investig Drugs; 2013 Aug; 22(8):993-1005. PubMed ID: 23731078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibodies inhibiting IL-12, -23, and -17 for the treatment of psoriasis.
    Jeon C; Sekhon S; Yan D; Afifi L; Nakamura M; Bhutani T
    Hum Vaccin Immunother; 2017 Oct; 13(10):2247-2259. PubMed ID: 28825875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 2013 Annual Autumn Meeting of the British Society of Heart Failure.
    Cullington D
    Expert Rev Cardiovasc Ther; 2014 Feb; 12(2):139-43. PubMed ID: 24450512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efalizumab in the treatment of psoriasis: when comorbidity is an issue.
    Prignano F; Buggiani G; Lotti T
    Dermatol Ther; 2008 Oct; 21 Suppl 2():S25-9. PubMed ID: 18837730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The therapeutic potential of TNF-alpha antagonists for skin psoriasis comorbidities.
    Piérard GE; Piérard-Franchimont C; Szepetiuk G; Paquet P; Quatresooz P
    Expert Opin Biol Ther; 2010 Aug; 10(8):1197-208. PubMed ID: 20560729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunologic targets in psoriasis.
    Kupper TS
    N Engl J Med; 2003 Nov; 349(21):1987-90. PubMed ID: 14627782
    [No Abstract]   [Full Text] [Related]  

  • 16. [The treatment of psoriasis: basic principles and new options].
    Vereecken P; Provost P; Willaert F; Heenen M; Bentin J
    Rev Med Brux; 2007 Sep; 28(4):336-44. PubMed ID: 17958030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent expression of CD26/DPPIV after treatment with infliximab in psoriasis despite clinical improvement.
    van Lingen RG; van Erp PE; Seyger MM; de Jong EM; de Boer-van Huizen RT; Driessen RJ; van de Kerkhof PC
    Acta Derm Venereol; 2009; 89(5):518-20. PubMed ID: 19734982
    [No Abstract]   [Full Text] [Related]  

  • 18. National Asthma Campaign International Congress. 8-10 June 1999, London, UK.
    Kelly D
    IDrugs; 1999 Aug; 2(8):750-3. PubMed ID: 16127646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical conferences for physicians: Who sets the agenda?
    Abakumova TR; Safina AF; Ziganshina LE
    Int J Risk Saf Med; 2015; 27 Suppl 1():S91-2. PubMed ID: 26639730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Summary of the International Federation of Psoriasis Associations (IFPA) meeting: a report from the GRAPPA 2009 annual meeting.
    Coates LC; Jonckheere CL; Molin S; Mease PJ; Ritchlin CT
    J Rheumatol; 2011 Mar; 38(3):530-9. PubMed ID: 21362781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.